Property:Dosage and regime
This is a property of type Text.
A
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
1g; 2x daily
Duration: day -2 chemotherapy until 20 days after the end of the chemotherapy cycle for 4 chemotherapy cycles +
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
1g; 2x daily
Duration: day -2 chemotherapy until 20 days after the end of the chemotherapy cycle for 4 chemotherapy cycles +
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
oral, 200mg, 2x daily
Duration: day -2 chemotherapy until 20 days after the end of the chemotherapy cycle for 4 chemotherapy cycles +
B
Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=77)
- 1 placebo daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=190)
- 2 placebos daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=79)
- 30mg Betacarotin + 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=194)
- 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=77)
- 1 placebo daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=190)
- 2 placebos daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=79)
- 30mg Betacarotin + 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=194)
- 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=77)
- 1 placebo daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=190)
- 2 placebos daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients +
In 1996 (2 years after the start of the study) the beta-carotene intervention was discontinued due to indications of harmful effects. Therefore 2 types of "Dosage and regime" (old, i.e. before 1996 and new, i.e. after 1996) are reported.
'''OLD''' (n=79)
- 30mg Betacarotin + 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy, median (range): 320 (21-609) days
'''NEW''' (n=194)
- 400 IU Vitamin E daily, start with first day of radiotherapy
- Duration: up to 3 years after radiotherapy +
Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors +
800 IU daily (2x 400 IU) +
Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors +
twice daily +
Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 +
60mg; 2x daily (daily dose 120mg) +
Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 +
2x daily +
Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators +
Placebo orally (high concentration formulation of calcitriol), weekly for 3 consecutive weeks of a 4-week cycle +
Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators +
DN-101 (45 μg) orally (high concentration formulation of calcitriol), weekly for 3 consecutive weeks of a 4-week cycle +
Bossi et al. (2017): A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin +
Daily dose 4 Placebo capsule, i.e. 2 capsules in the morning and 2 capsules in the late afternoon, starting the day after chemotherapy for 42-56 days (depending on duration of chemotherapy) +
Bossi et al. (2017): A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin +
Daily dose 4x40mg ginger capsule (“Ginger CO2 supercritical extract”), i.e. 2 capsules in the morning and 2 capsules in the late afternoon, starting the day after chemotherapy for 42-56 days (depending on duration of chemotherapy) +
Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer +
2 placebo capsules/ day (composed of wheat starch with no added zinc)
+ vaccination with 1 dose of 0.5 mL of 23-valent pneumococcal polysaccharide vaccine (Pneumovax 23 , Merck, Whitehouse Station, NJ), containing 25 mg of capsular polysaccharide antigen from 23 different pneumococcal serotypes (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F); 2 days after zinc supplementation started +
Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer +
2 zinc sulfate capsules/ day (each containing 35 mg of elemental zinc); first capsule 1h after breakfast and the other 1h after dinner
+ vaccination with 1 dose of 0.5 mL of 23-valent pneumococcal polysaccharide vaccine (Pneumovax 23 , Merck, Whitehouse Station, NJ), containing 25 mg of capsular polysaccharide antigen from 23 different pneumococcal serotypes (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F); 2 days after zinc supplementation started +
Braik et al. (2014): Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy +
Oral 100mg/day from first day of chemotherapy, daily +